Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-07-08 4:32 pm Sale | 13G | Kezar Life Sciences Inc. KZR | BlackRock Inc. BLK | 830,371 1.1% | -3,986,895![]() (-82.76%) | View |
2024-02-14 6:47 pm Sale | 13G | Kezar Life Sciences Inc. KZR | ORBIMED ADVISORS LLC | 1,927,000 2.7% | -1,568,122![]() (-44.87%) | View |
2024-02-14 6:44 pm Purchase | 13G | Kezar Life Sciences Inc. KZR | BARCLAYS PLC BCS | 3,828,782 5.27% | 3,828,782![]() (New Position) | View |
2024-02-14 06:50 am Sale | 13G | Kezar Life Sciences Inc. KZR | Avidity Partners Management LP | 5,025,454 6.9% | -1,756,946![]() (-25.90%) | View |
2024-02-13 11:55 am Purchase | 13G | Kezar Life Sciences Inc. KZR | SUVRETTA CAPITAL MANAGEMENT LLC | 7,167,591 9.9% | 3,663,327![]() (+104.54%) | View |
2024-02-13 09:50 am Sale | 13G | Kezar Life Sciences Inc. KZR | Prosight Management LP | 3,365,333 4.6% | -707,896![]() (-17.38%) | View |
2024-01-29 3:26 pm Purchase | 13G | Kezar Life Sciences Inc. KZR | BlackRock Inc. BLK | 4,817,266 6.6% | 586,353![]() (+13.86%) | View |
2024-01-23 09:15 am Sale | 13G | Kezar Life Sciences Inc. KZR | STATE STREET CORP STT | 1,116,052 1.54% | -3,137,908![]() (-73.76%) | View |
2024-01-22 4:04 pm Sale | 13G | Kezar Life Sciences Inc. KZR | MILLENNIUM MANAGEMENT LLC | 2,927,563 4% | -852,971![]() (-22.56%) | View |
2023-08-17 5:14 pm Unchanged | 13D | Kezar Life Sciences Inc. KZR | Morningside Venture Investments Ltd | 6,254,545 8.6% | 0 (Unchanged) | View |
2023-06-21 4:02 pm Purchase | 13G | Kezar Life Sciences Inc. KZR | MILLENNIUM MANAGEMENT LLC | 3,780,534 5.2% | 884,039![]() (+30.52%) | View |
2023-04-20 6:20 pm Purchase | 13G | Kezar Life Sciences Inc. KZR | Prosight Management LP | 4,073,229 5.8% | 4,073,229![]() (New Position) | View |
2023-02-14 4:32 pm Purchase | 13G | Kezar Life Sciences Inc. KZR | ORBIMED ADVISORS LLC | 3,495,122 5.1% | 3,495,122![]() (New Position) | View |
2023-02-14 4:20 pm Sale | 13G | Kezar Life Sciences Inc. KZR | BB BIOTECH AG | 3,000,000 4.4% | -1,918,148![]() (-39.00%) | View |
2023-02-14 3:44 pm Purchase | 13G | Kezar Life Sciences Inc. KZR | Avidity Partners Management LP | 6,782,400 9.9% | 3,554,200![]() (+110.10%) | View |
2023-02-13 10:27 am Purchase | 13G | Kezar Life Sciences Inc. KZR | SUVRETTA CAPITAL MANAGEMENT LLC | 3,504,264 5.1% | 362,464![]() (+11.54%) | View |
2023-02-03 4:27 pm Purchase | 13G | Kezar Life Sciences Inc. KZR | BlackRock Inc. BLK | 4,230,913 6.2% | 1,359,669![]() (+47.35%) | View |
2023-02-03 2:53 pm Purchase | 13G | Kezar Life Sciences Inc. KZR | STATE STREET CORP STT | 4,253,960 6.22% | 4,253,960![]() (New Position) | View |
2023-01-31 2:39 pm Sale | 13G | Kezar Life Sciences Inc. KZR | FRANKLIN RESOURCES INC BEN | 1,365,323 2% | -1,120,863![]() (-45.08%) | View |
2023-01-17 4:15 pm Sale | 13G | Kezar Life Sciences Inc. KZR | MILLENNIUM MANAGEMENT LLC | 2,896,495 4.2% | -130,133![]() (-4.30%) | View |